Entries by Andrew Humphreys

, , , , , , ,

Biogen sales face pressure from slow uptake of Alzhiemer’s drug

Biogen Inc.’s Alzheimer’s drug will be of little help to the company’s third-quarter sales, Wall Street analysts said, as the drugmaker faces an uphill task of convincing hospitals and clinics to use the $56,000-a-year treatment and insurers to reimburse Aduhelm.

, , , , , , , , , ,

Lilly’s Longest Diabetes Drug Trial Lowers A1C and Increases Weight Loss

The latest results from SURPASS-4, the longest and largest completed SURPASS trial to date, showed consistent activity in maintaining A1C and weight control in the almost two years the study ran. SURPASS-4 is part of the Phase III trial evaluating tirzepatide as a potential treatment for type 2 diabetes. 

, , , , , , , , , , ,

Vaccines less protective for multiple myeloma patients; beware of fake stem cell treatment claims for COVID-19

Coronavirus vaccines are known to be less protective in people with the blood cancer multiple myeloma, such as former U.S. Secretary of State Colin Powell, who died on Oct. 18 of complications from Covid-19 despite being fully vaccinated. Additionally, in a paper in the journal Stem Cell Reports, researchers said numerous businesses have made unsubstantiated and inaccurate claims about supposed stem cell products to treat Covid-19.

, , , , , , , , , , , , , ,

FDA OKs Gilead’s Pediatric HIV Treatment and Boehringer’s Humira Biosimilar

The U.S. Food and Drug Administration greenlit a new indication for Gilead Sciences’ drug Biktarvy for pediatric patients with HIV who are virologically suppressed or new to antiretroviral therapy.